AI assistant
CYTOKINETICS INC — Director's Dealing 2013
Jan 4, 2013
30870_dirs_2013-01-04_ffd8f3aa-f818-45e2-ac5e-1434561f7735.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2013-01-02
Reporting Person: SMITH SANDFORD D (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-01-02 | Non-Qualified Stock Option (right to buy) | $0.6702 | A | 65279 | Acquired | 2023-01-02 | Common Stock (65279) | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy) | $0.91 | 2022-05-22 | Common Stock (25000) | 25000 | Direct |
| Non-Qualified Stock Option (right to buy) | $1.05 | 2022-03-05 | Common Stock (40000) | 40000 | Direct |
| Non-Qualified Stock Option (right to buy) | $1.14 | 2022-04-02 | Common Stock (16447) | 16447 | Direct |
Footnotes
F1: This option shall vest and become exercisable as to 65,279 shares divided into equal monthly installments such that the option shall be 100% vested on January 2, 2014.
F2: This option was issued to the reporting person pursuant to the Cytokinetics 2004 Equity Incentive Plan in lieu of an annual retainer of $35,000.
F3: This option shall vest and become exercisable as to 25,000 shares divided into equal monthly installments such that the option shall be 100% vested on May 22, 2013.
F4: This option shall vest and become exercisable as to 40,000 shares divided into equal monthly installments such that the option shall be 100% vested on March 5, 2015.
F5: This option shall vest and become exercisable as to 16,447 shares divided into equal monthly installments such that the option shall be 100% vested on January 2, 2013.